Every grid keeps a fleet of 'peaker' plants — usually gas turbines — that sit idle most of the year and roar to life on the few brutal afternoons when demand spikes. They are expensive, dirty, and exactly the thing the energy transition wants to retire. The replacement has a name: the renewable peaker, and a 2022 Fluence patent shows how it is built.

The concept is solar plus storage doing a peaker's job. Solar produces cheaply during the day; a battery banks that energy and releases it during the late-afternoon and evening demand peak, when solar is fading but air conditioners are still running. Together they can dispatch power on demand during peak hours — the defining function of a peaker — without burning anything.

What makes Fluence's grant US11309708B2, "Utility-scale renewable peaker plant, tightly coupled solar PV and energy storage," worth reading is the phrase tightly coupled. You can build solar-plus-storage as two separate plants that happen to share a site, each with its own power electronics and grid connection. Or you can integrate them — share inverters, share the interconnection, route DC power from panels straight into the battery. Tight coupling is the cheaper, more efficient path, and it is the engineering the patent claims.

Why coupling is the real story: the single biggest cost-and-delay item for any utility-scale project is the grid interconnection. Two plants need two; a tightly coupled plant needs one. Sharing the inverter and the connection is not a footnote — it is how the economics of replacing a gas peaker actually close. Megawatts on paper are easy; a financeable, single-interconnection plant is the thing that gets built.

Fluence is a serious storage developer, so this is not a paper concept floating free of the market — but a patent is still a description of a configuration, not a record of any specific plant's performance. Read it as the design logic behind a whole category of projects now displacing gas peakers, and as a reminder that the cleverest part is often the shared wiring, not the cells.